ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial
Radiology
◽
10.1148/radiol.2021202717
◽
2021
◽
Vol 298
(3)
◽
pp. 695-703
◽
Cited By ~ 1
Author(s):
Sangeet Ghai
◽
Antonio Finelli
◽
Kateri Corr
◽
Rosanna Chan
◽
Sarah Jokhu
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Focused Ultrasound
◽
Phase Ii Trial
◽
Intermediate Risk
◽
Early Results
◽
Risk Prostate Cancer
◽
Ultrasound Ablation
◽
Mri Guided
◽
Focused Ultrasound Ablation
Download Full-text
Related Documents
Cited By
References
MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial
Radiology
◽
10.1148/radiol.2021219007
◽
2021
◽
Vol 299
(2)
◽
pp. E258-E258
Author(s):
Sangeet Ghai
◽
Antonio Finelli
◽
Kateri Corr
◽
Rosanna Chan
◽
Sarah Jokhu
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Focused Ultrasound
◽
Phase Ii Trial
◽
Intermediate Risk
◽
Early Results
◽
Risk Prostate Cancer
◽
Ultrasound Ablation
◽
Mri Guided
◽
Focused Ultrasound Ablation
Download Full-text
LBA02-06 PHASE IIB MULTICENTER STUDY ON MRI-GUIDED FOCUSED ULTRASOUND (MRGFUS) FOCAL THERAPY FOR INTERMEDIATE RISK PROSTATE CANCER
The Journal of Urology
◽
10.1097/ju.0000000000000958.06
◽
2020
◽
Vol 203
◽
pp. e1117
Author(s):
Behfar Ehdaie*
◽
Clare Tempany
◽
Ford Holland
◽
Adam Kibel
◽
Quoc-Dien Trinh
◽
...
Keyword(s):
Prostate Cancer
◽
Multicenter Study
◽
Focused Ultrasound
◽
Focal Therapy
◽
Intermediate Risk
◽
Risk Prostate Cancer
◽
Mri Guided
Download Full-text
LBA02-12 MRI-GUIDED FOCUSED ULTRASOUND (MRgFUS) FOCAL THERAPY FOR INTERMEDIATE-RISK PROSTATE CANCER: FINAL RESULTS OF A PHASE IIB MULTICENTER STUDY
The Journal of Urology
◽
10.1097/ju.0000000000002149.12
◽
2021
◽
Vol 206
(Supplement 3)
◽
Author(s):
Behfar Ehdaie
◽
Clare Tempany
◽
Ford Holland
◽
Adam Kibel
◽
Quoc-Dien Trinh
◽
...
Keyword(s):
Prostate Cancer
◽
Multicenter Study
◽
Focused Ultrasound
◽
Focal Therapy
◽
Intermediate Risk
◽
Risk Prostate Cancer
◽
Mri Guided
Download Full-text
80 Toxicity and Quality of Life Results from a Randomized Phase II Trial of HDR Monotherapy for Low and Intermediate-Risk Prostate Cancer
Radiotherapy and Oncology
◽
10.1016/s0167-8140(19)33371-7
◽
2019
◽
Vol 139
◽
pp. S36
Author(s):
Yaser Hasan
◽
Andrew Loblaw
◽
Hans Chung
◽
Merrylee McGuffin
◽
Chia-Lin Tseng
◽
...
Keyword(s):
Quality Of Life
◽
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Intermediate Risk
◽
Randomized Phase Ii
◽
Risk Prostate Cancer
Download Full-text
Toxicity and Quality of Life Results from a Randomized Phase II Trial of HDR Monotherapy for Low and Intermediate-Risk Prostate Cancer
Brachytherapy
◽
10.1016/j.brachy.2019.04.113
◽
2019
◽
Vol 18
(3)
◽
pp. S53-S54
Author(s):
Yaser Hasan
◽
Andrew Loblaw
◽
Hans Chung
◽
Merrylee McGuffin
◽
Chia-Lin Tseng
◽
...
Keyword(s):
Quality Of Life
◽
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Intermediate Risk
◽
Randomized Phase Ii
◽
Risk Prostate Cancer
Download Full-text
Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial
BJU International
◽
10.1111/bju.14925
◽
2019
◽
Vol 125
(2)
◽
pp. 215-225
Author(s):
Victor A. Macias
◽
Inmaculada Barrera-Mellado
Keyword(s):
Prostate Cancer
◽
Radiation Therapy
◽
High Risk
◽
Phase Ii
◽
Phase Ii Trial
◽
Intermediate Risk
◽
High Risk Prostate Cancer
◽
Risk Prostate Cancer
◽
Hypofractionated Radiation Therapy
◽
Hypofractionated Radiation
Download Full-text
UP-2.161: Focal High Intensity Focused Ultrasound (HIFU) Therapy in the Treatment of Localised Prostate Cancer: Early Results of a Phase II Trial
Urology
◽
10.1016/j.urology.2009.07.380
◽
2009
◽
Vol 74
(4)
◽
pp. S282
Author(s):
M. Sahu
◽
H. Ahmed
◽
S. Kumaar
◽
N. Arumainayagam
◽
K. Rogers
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
High Intensity
◽
Focused Ultrasound
◽
Phase Ii Trial
◽
High Intensity Focused Ultrasound
◽
Early Results
Download Full-text
EP-1774: Randomized phase II trial of IGRT with or without HDR boost in intermediate-risk prostate cancer
Radiotherapy and Oncology
◽
10.1016/s0167-8140(17)32136-9
◽
2017
◽
Vol 123
◽
pp. S975-S976
◽
Cited By ~ 1
Author(s):
E. Vigneault
◽
G. Morton
◽
W. Perulekar
◽
T. Niazi
◽
G. Springer
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Intermediate Risk
◽
Randomized Phase Ii
◽
Risk Prostate Cancer
Download Full-text
Toxicity and Quality of Life Outcomes from a Randomized Phase II Trial of HDR Monotherapy for Low and Intermediate-Risk Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/j.ijrobp.2019.06.120
◽
2019
◽
Vol 105
(1)
◽
pp. S133
Author(s):
Y. Hasan
◽
D.A. Loblaw
◽
H.R. Chung
◽
M. McGuffin
◽
C.L. Tseng
◽
...
Keyword(s):
Quality Of Life
◽
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Intermediate Risk
◽
Life Outcomes
◽
Quality Of Life Outcomes
◽
Randomized Phase Ii
◽
Risk Prostate Cancer
Download Full-text
High-Dose-RATE Brachytherapy As Monotherapy for Low and Intermediate Risk Prostate Cancer: ACUTE Toxicity of a Randomized Phase II Trial
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/j.ijrobp.2019.06.1818
◽
2019
◽
Vol 105
(1)
◽
pp. E284
Author(s):
M. Jolicoeur
◽
T. Derashodian
◽
T.V. Nguyen-Huynh
◽
E. de Castro Hellmann
◽
M. Mondat
◽
...
Keyword(s):
Prostate Cancer
◽
Acute Toxicity
◽
Dose Rate
◽
Phase Ii
◽
Phase Ii Trial
◽
High Dose Rate
◽
High Dose
◽
Intermediate Risk
◽
Randomized Phase Ii
◽
Risk Prostate Cancer
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close